Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Billington

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Design and Discovery|November 1, 1991
Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic diseasesD C Billington
Drug Design and Discovery|January 7, 2000
Driving drug discovery and patient therapy via the encapsulation and fusion of knowledgeM A Collins, I Shaw, D C Billington
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part Two: Construction of a library of 4-amino-5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
The Biochemical Journal|September 15, 1979
Biosynthesis of ethylene from methionine. Isolation of the putative intermediate 4-methylthio-2-oxobutanoate from culture fluids of bacteria and fungiD C Billington, B T Golding, S B Primrose
Acta Crystallographica. Section C, Crystal Structure Communications|July 21, 2004
A new amidrazone derivative with antimycobacterial activityD C Billington, P R Lowe, D L Rathbone, et al.
Drug Design and Discovery|July 27, 2001
Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonistsE Lattmann, D C Billington, D R Poyner, et al.
Environmental Toxicology and Pharmacology|February 13, 2001
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds IIIM D. Coleman, D L. Rathbone, R Chima, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compoundsM D Coleman, D L Rathbone, L Abberley, et al.
Archiv Der Pharmazie|March 31, 2006
Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-ones and their evaluation as cholecystokinin-ligandsMichael Offel, Pornthip Lattmann, Harjit Singh, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Design and Discovery|November 1, 1991
Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic diseasesD C Billington
Drug Design and Discovery|January 7, 2000
Driving drug discovery and patient therapy via the encapsulation and fusion of knowledgeM A Collins, I Shaw, D C Billington
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part Two: Construction of a library of 4-amino-5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
The Biochemical Journal|September 15, 1979
Biosynthesis of ethylene from methionine. Isolation of the putative intermediate 4-methylthio-2-oxobutanoate from culture fluids of bacteria and fungiD C Billington, B T Golding, S B Primrose
Acta Crystallographica. Section C, Crystal Structure Communications|July 21, 2004
A new amidrazone derivative with antimycobacterial activityD C Billington, P R Lowe, D L Rathbone, et al.
Drug Design and Discovery|July 27, 2001
Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonistsE Lattmann, D C Billington, D R Poyner, et al.
Environmental Toxicology and Pharmacology|February 13, 2001
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds IIIM D. Coleman, D L. Rathbone, R Chima, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compoundsM D Coleman, D L Rathbone, L Abberley, et al.
Archiv Der Pharmazie|March 31, 2006
Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-ones and their evaluation as cholecystokinin-ligandsMichael Offel, Pornthip Lattmann, Harjit Singh, et al.
Pageof 2